Document is current
Any future updates will be listed below
-
Authors
Muller, C. O.
Faity, G.
Muthalib, M.
Perrey, S.
Dray, G.
Xu, B.
Froger, J.
Mottet, D.
Laffont, I.
Delorme, M.
Bakhti, K.
-
Funding
Funding for this research was provided by:
Direction générale de l’offre de soins (DGOS), French Ministère des Affaires Sociales et de la Santé (PHRIP-2018-0731)
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 6 September 2024
First Online: 22 October 2024
Declarations
:
: This study was conducted as part of the ReArm clinical trial (ID-RCB 2019-A00506-51) following ethical approval by the French Committee for the Protection of Individuals (CPP SUD-EST II) for patient inclusion. In addition, the local ethics committee approved the protocol for healthy participants (IRB-EM 1912B). All participants gave written informed consent prior to taking part in the study.
: All authors give their consent to publish.
: The authors declare no competing interests.
